Symbol="PMCB"
AssetType="Common Stock"
Name="PharmaCyte Biotech Inc"
Description="PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United States. The company is headquartered in Laguna Hills, California."
CIK="1157075"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="MEDICINAL CHEMICALS & BOTANICAL PRODUCTS"
Address="23046 AVENIDA DE LA CARLOTA, SUITE 600, LAGUNA HILLS, CA, US"
FiscalYearEnd="April"
LatestQuarter="2023-04-30"
MarketCapitalization="21155200"
EBITDA="None"
PERatio="None"
PEGRatio="0"
BookValue="4.328"
DividendPerShare="0"
DividendYield="0"
EPS="-0.22"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.0492"
ReturnOnEquityTTM="-0.0531"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.22"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.654"
EVToRevenue="-"
EVToEBITDA="-11.23"
Beta="-0.0291"
num_52WeekHigh="3.23"
num_52WeekLow="2.3"
num_50DayMovingAverage="2.716"
num_200DayMovingAverage="2.901"
SharesOutstanding="8778100"
DividendDate="None"
ExDividendDate="None"
symbol="PMCB"
open="2.38"
high="2.47"
low="2.38"
price="2.44"
volume="16486.00"
latest_trading_day="2023-08-28"
previous_close="2.40"
change="0.04"
change_percent="1.8194%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="48"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="52"
Volume_recent_avg="41061"
Change_recent_avg="0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.02"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="52"
Aroon_momentum_negative="48"
image_negative_thumbnail_id_1="143"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0033.jpeg"
image_negative_thumbnail_id_2="156"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0020.jpeg"
image_neutral_thumbnail_id_1="569"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="1007"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0169.jpeg"
image_positive_thumbnail_id_2="632"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0076.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
